Following news last week that it has begun appointing distributors for Remplir in the United States, Orthocell has announced clearance to begin selling the nerve repair product in Canada, a market it estimates to be worth $US 75 million. In an ASX statement on Wednesday, Orthocell said it has received a Medical Device Licence (MDL)…
Battery chemical recycler and manufacturer Livium has commenced a deal to provide services to metal recycling business Sell & Parker, anticipated to generate revenues of $3 million in the next 12 months and offering potential “to be Livium’s largest ever recycling contract”. According to a statement from Livium on Thursday, the three-year subcontractor deal with…
Governor-General to join Good Design Australia as Patron Design advocacy body Good Design Australia announced on Tuesday that the Governor-General, Sam Mostyn, will become the Patron of the organisation, in what it said was a “historic appointment signal[ing] the critically important role of design in shaping Australia’s future.” In a statement, the organisation said the…
Reproductive technology company Memphasys came out of a trading halt on Monday morning, telling investors that it has received binding commitments to raise $1.275 million through a strategic placement. In a statement to the ASX, Memphasys said the commitments were from new and existing shareholders, amounting to 212,500,000 ordinary shares at $0.006 per share. Participants…
Implantable hearing aid manufacturer Cochlear has said it is seeking clarification on the application of new tariffs on Australian exports to the United States. Its statement on Thursday morning swiftly followed the “Liberation Day” announcement by US president Donald Trump of tariffs on all importers to the US. Australian exports face the baseline rate of…
Australian microbiome health company Biome Australia reported a 41 per cent increase in quarterly sales revenue to $4.5 million for Q3 FY25 compared to the same period last year, according to an ASX announcement on Tuesday. The company’s financial year to date sales reached $13.4 million, representing a 46 per cent increase on the previous…
Cyclopharm’s lung imaging technology is breathing new life into the company’s bottom line, with its Technegas product surpassing the million-dollar milestone in US sales, according to Tuesday’s ASX announcement. The Sydney-based company has rapidly expanded its American footprint, with Technegas systems now installed in 27 US medical facilities as of 31 March 2025 – a…
Forbidden Foods reported a 171 per cent increase in net sales for the March quarter compared to the same period last year, according to an ASX announcement on Tuesday. The health and wellness food company achieved $1.1 million in net sales for Q3 FY25, maintaining consistency with the previous quarter following its strategic acquisition of…
Hanwha, Elphinstone sign contract for Redback hulls Hanwha Defence Australia (HDA) and Elphinstone have signed a contract for manufacture of “all 129 vehicle hull structures” for the Redback family of Infantry Fighting Vehicles under LAND 400 Phase 3 program. In a statement over the weekend, HDA said the work by Elphinstone under the contract is…
Memphasys claims defining milestone for Felix Reproductive technology company Memphasys has announced the successful data from a “pivotal clinical trial” for the Felix System, “confirming its best-in-class performance in sperm selection for Assisted Reproductive Technology (ART).” Conducted in partnership through Monash IVF, Memphasys said on Monday that the trial results show Felix as “non-inferior to…